Emerging Privacy Laws for Wearable Health Devices
Post Summary
Wearable health devices are reshaping how personal health data is collected and used, but privacy concerns are growing. Here's what you need to know:
- Data Risks: Health records from wearables are highly valuable, with breaches exposing millions of records in recent years.
- Regulatory Gaps: U.S. laws like HIPAA don’t cover consumer-generated wearable data, leaving sensitive information vulnerable.
- New U.S. Laws: Federal and state initiatives, such as the proposed Health Information Privacy Reform Act (HIPRA) and Washington's My Health My Data Act, aim to tighten protections.
- Global Trends: The EU's GDPR and new regulations in Asia-Pacific countries impose stricter rules on health data, requiring explicit consent and enhanced security measures.
- Compliance Challenges: Companies must navigate overlapping federal, state, and international rules while ensuring robust data security.
As wearable devices evolve, privacy laws are catching up. Businesses must stay ahead by treating user data with care and adopting strong compliance strategies.
Should You Be Worried About Smartwatch Health Data Privacy? - The Hardware Hub
sbb-itb-535baee
Key U.S. Privacy Regulations Affecting Wearable Health Devices
U.S. & Global Privacy Laws for Wearable Health Devices: Key Regulations Compared
Privacy rules around wearable health devices are evolving rapidly in the U.S. Federal and state governments are stepping in to address gaps left by HIPAA, pushing companies to adopt stricter practices for handling sensitive data. Let’s explore the key regulations shaping this space.
Health Information Privacy Reform Act (S.B. 3097)
Introduced by Senator Bill Cassidy on November 4, 2025, the Health Information Privacy Reform Act (HIPRA) aims to extend HIPAA-like protections to data generated by wearables like Apple Watches and Oura Rings. With one in three Americans using these devices to track health metrics, the bill addresses the lack of federal safeguards for such data [5].
HIPRA introduces the term "applicable health information" to cover identifiable health data from consumer devices - not just traditional medical records [4][6]. It categorizes wearable manufacturers and health app developers as "regulated entities" subject to HIPAA-like standards. These include:
- Written authorization for certain data disclosures
- "Minimum necessary" data use policies
- Security measures following NIST or HHS cybersecurity frameworks [4][6]
A key provision requires companies to provide clear notices that wellness data - like step counts and heart rate - is not HIPAA-protected. Users must also have the option to opt out of data collection entirely [4]. The bill prohibits selling health data without explicit consent and sets national standards for de-identifying health information [4][6].
"HIPRA is intended to account for new technologies that are not currently required to have privacy protections, such as smartwatches and health apps." - U.S. Senate Committee on Health, Education, Labor, and Pensions [6]
While still in the proposal stage, HIPRA highlights the federal government's focus on wearable health data [6].
FTC Health Breach Notification Rule Amendments
Unlike HIPRA, the Federal Trade Commission’s Health Breach Notification Rule (HBNR) amendments are already in effect as of July 2024. These changes expand the rule to include health apps, fitness trackers, and connected devices not covered by HIPAA [7][8].
The updated rule broadens the definition of a "breach" to include unauthorized data sharing. For example, if a company shares users' health data with advertisers without clear consent, it qualifies as a breach [7][8]. The FTC clarified:
"The Rule's definition of a breach makes clear that the Rule does not just apply to cybersecurity intrusions or other nefarious behavior. To the contrary, if you disclose consumers' unsecured, individually identifiable health information without their consent, a breach has occurred." - Federal Trade Commission [8]
Violations can result in penalties of up to $53,088 per incident [8]. For breaches affecting 500 or more individuals, companies must notify users and the FTC within 60 days. If the breach involves 500 or more residents of a single state, media outlets must also be informed [7][8]. Recent enforcement actions against GoodRx and Easy Healthcare in 2024 show that the FTC is actively pursuing offenders [7].
State Laws: Washington My Health My Data Act (MHMDA) and California Privacy Rights Act (CPRA)
At the state level, Washington’s My Health My Data Act (MHMDA) and California’s Privacy Rights Act (CPRA) stand out for their strict requirements on wearable health data. Both laws, effective in 2024, target companies that fall outside HIPAA’s jurisdiction.
Washington’s MHMDA is considered the strictest health data law in the U.S. It covers data that’s "collected, derived, or inferred", meaning even metrics like stress levels or menstrual cycle predictions are included [3][5]. Key provisions include:
- Opt-in consent for collecting sensitive health data
- Separate authorization for selling such data
- A ban on geofencing within 1,750 feet of reproductive health facilities, affecting location-aware apps [3]
California’s CPRA treats wearable metrics - such as heart rate, skin temperature, and sleep patterns - as "sensitive personal information." Consumers can opt out of the sale or use of this data. Additionally, the law requires Data Protection Impact Assessments (DPIAs) for high-risk processing activities [3].
| Feature | Washington MHMDA | California CPRA |
|---|---|---|
| Data Scope | Covers "derived or inferred" health metrics [3] | Classifies wearable metrics as "sensitive" [3] |
| Consent Model | Opt-in for collection; separate authorization for sale [3] | Right to opt out of sale or use [3] |
| Unique Provision | Bans geofencing near reproductive health facilities (1,750 ft) [3] | Requires DPIAs for high-risk activities [3] |
For companies operating nationwide, compliance can be tricky. By late 2025, 19 states had laws treating consumer health data as sensitive [5]. Ten states, including California and Colorado, require opt-in consent for health data processing, while others like Texas use narrower definitions tied to formal diagnoses [5]. Experts recommend following the strictest standards - currently Washington and Maryland - and applying them across the board [5].
Global Privacy Trends for Wearable Health Devices
As wearable devices continue to gain popularity worldwide, privacy standards are tightening across global markets. With wearable shipments projected to grow by 6.1% in 2024 and smartwatch users expected to hit 740 million globally by 2029 [2], privacy regulations are becoming a critical focus for businesses. Keeping up with these international trends is no longer optional - it's essential for staying competitive. Regulatory frameworks like the EU's GDPR are leading the charge with some of the world's strictest data protection rules.
EU General Data Protection Regulation (GDPR) and Its Impact on Wearables
Under the GDPR, biometric and health data fall into "special categories" as outlined in Article 9. This means companies must obtain explicit consent before collecting or processing such data. Unlike HIPAA, which primarily applies when a company works as a business associate for a healthcare entity, GDPR doesn't make this distinction. If your wearable device collects health data from an EU resident, you're bound by its rules.
For connected medical wearables, GDPR compliance involves several steps, including conducting a Data Protection Impact Assessment (DPIA), appointing an EU Authorized Representative, and, starting May 28, 2026, registering with EUDAMED. Adding to this, the EU AI Act, effective since August 2024, classifies biometric and health-monitoring AI as "high-risk" technologies. This classification requires companies to ensure transparency, implement human oversight, and manage risks formally.
"The EU model contrasts sharply with the United States, illustrating the trade-offs between rights-based governance and rapid innovation while positioning the region as a global leader in ethical AI." - Anastasia Vener, AI and Privacy Governance Strategist [10]
For U.S.-based companies looking to operate in Europe, compliance options include self-certifying under the EU-US Data Privacy Framework (DPF) or relying on Standard Contractual Clauses (SCCs) for cross-border data transfers. Additionally, adopting ISO 14971 for risk management can help meet both FDA and EU MDR requirements.
Privacy Regulations in Asia-Pacific
While the EU sets the tone with its stringent standards, the Asia-Pacific region is crafting its own regulatory landscape. For example, South Korea's Basic Act on the Development of Artificial Intelligence, effective January 2026, categorizes wearable health-monitoring devices as "high-impact AI systems." This classification requires oversight by humans and formal risk assessments [10]. Meanwhile, Japan's APPI amendments, approved in April 2026, introduce stricter rules for biometric data. These amendments allow users to demand an immediate stop to the use of their data, such as facial recognition, while also creating a narrow exemption for AI research under strict conditions [11].
China has also updated its standards as of September 2025, enforcing AI-generated content labeling and requiring companies to register large-scale biometric data collection [10]. A study from 2025/2026 revealed that 76% of wearable manufacturers were rated "High Risk" for transparency in data sharing [2], with APAC-based companies like Xiaomi and Huawei receiving the highest cumulative privacy risk scores [2].
"The Asia-Pacific region is transitioning from voluntary frameworks toward binding AI governance, especially in sectors like health and biometrics where wearable devices operate." - Anastasia Vener, AI and Privacy Governance Strategist [10]
Here’s a snapshot of key APAC regulations affecting wearables:
| Country | Key Regulation | Status | Focus for Wearables |
|---|---|---|---|
| South Korea | Basic Act on AI | Effective Jan. 2026 | High-impact AI classification; human oversight [10] |
| Japan | APPI Amendments | Approved April 2026 | Biometric tracking rules; AI research exemptions [11] |
| China | PIPL / AI Standards | Updated Sept. 2025 | Mandatory AI labeling; biometric consent registration [10] |
| India | Digital India Bill | Proposed/Emerging | Connected device supervision; risk classification [10] |
| Australia | TGA Sector Reforms | Ongoing 2025/2026 | Therapeutic Goods Administration oversight [10] |
For U.S. companies operating globally, it’s critical to map data flows, implement detailed consent processes, and design devices with privacy as a default to take the risk out of healthcare. These measures not only address individual jurisdictions but also create a robust, multi-region compliance foundation.
Challenges and Opportunities in Meeting Privacy Law Requirements
Data Security and Risk Management Requirements
Healthcare providers and wearable tech manufacturers navigate a maze of rules, including federal laws, FDA guidance, and varying state regulations. This patchwork makes staying compliant a complex task. Wearable device data, unlike traditional healthcare data, requires advanced technical protections and swift responses to breaches. Adding to the challenge, the classification of a product as an FDA-regulated "cyber device" or a "general wellness product" can drastically shift compliance requirements. Unfortunately, the distinction isn’t always straightforward [1].
"The absence of FDA oversight does not make these technologies low risk: whether regulated devices or general wellness products, they collect large volumes of sensitive data and remain attractive targets for cyber threats." - Kyle A. Dolinsky, Karla Ballesteros, Kaitlin J. Clemens, and Samarth Parikh [1]
Healthcare organizations now face stricter standards under updated HIPAA Security Rules and FDA guidelines. These include requirements like multi-factor authentication, data encryption (both in transit and at rest), regular security evaluations, and a detailed Cybersecurity Management Plan (CMP). The CMP must address personnel responsibilities, vulnerability monitoring, security testing, and patching schedules - establishing a new baseline for compliance.
Recent enforcement actions underline the urgency of these measures. For instance, fertility app developers have faced penalties for failing to encrypt data and delaying breach notifications. The FTC's Health Breach Notification Rule mandates that non-HIPAA entities notify both consumers and the FTC within 60 days of a breach [3]. Meanwhile, proposed HIPAA updates could reduce this timeline to just 24 hours for business associates [3]. These changes highlight the importance of having well-prepared and regularly tested incident response plans.
The growing complexity of these requirements underscores the demand for streamlined compliance solutions.
How Censinet Helps Simplify Compliance
Manually managing overlapping regulations, vendor agreements, and security assessments is becoming unmanageable. Censinet RiskOps™ offers a centralized platform to handle these challenges. It streamlines third-party and enterprise risk assessments, evaluates cybersecurity readiness, and automates security questionnaires using its integrated Censinet AI™ feature. This makes it easier to comply with mandates like MHMDA and CPRA. For healthcare organizations shifting from a less regulated past to a stricter governance landscape, a centralized, automated risk management system is no longer optional - it’s essential.
The Future of Privacy Laws for Wearable Health Devices
The landscape for regulating wearables is evolving rapidly. With U.S. retail sales of fitness trackers surging by 88% year-to-date in 2025 compared to 2024 [9], lawmakers are under growing pressure to establish stronger, more consistent privacy protections. It’s becoming increasingly clear that significant changes in privacy laws are on the horizon.
As wearable devices offer more advanced features - like ECG monitoring, blood pressure tracking, and AI-powered diagnostics - many are entering FDA-regulated territory. This shift triggers requirements such as Cybersecurity Management Plans, which currently apply to cyber devices. The use of AI diagnostics often classifies wearables as high-risk, requiring companies to implement strict data governance and ongoing risk management practices. For example, under frameworks like the EU AI Act, manufacturers must perform continuous post-market monitoring and adopt lifecycle-based risk management [12]. As wearable technology advances, new types of data - such as neural signals - are beginning to demand the same level of regulatory oversight.
Neural data is particularly noteworthy. Devices like sleep wearables that collect EEG signals are already prompting states like California, Colorado, and Connecticut to expand their definitions of protected health information to include neural data [5]. As this technology becomes more widespread, other states - and eventually federal regulators - are likely to follow suit. Companies handling neural data should treat it as highly sensitive to avoid compliance challenges down the road. These developments are paving the way for stricter state and federal regulations.
To stay ahead, organizations should align their privacy practices with the most stringent standards available. Jennifer Sheridan, Principal at JLSheridan Law, emphasizes this point: "These states are moving the nation closer to HIPAA-style protections for consumers where businesses would be wise to de-identify sensitive consumer health data before sharing or selling it" [5].
State-level actions are already shaping the regulatory environment. For example, New York’s Senate Bill 929 (Health Information Privacy Act), which is modeled after Washington’s My Health My Data Act, was awaiting the governor’s signature as of late 2025 [5]. Maryland has taken an even stricter stance, banning the sale of sensitive health data for targeted advertising - even with user consent [5]. These state initiatives highlight a growing national trend toward robust consumer data protection. Companies that only meet today’s minimum requirements may face expensive adjustments as federal standards eventually catch up.
Conclusion: Navigating the Changing Privacy Landscape
The scrutiny around wearable health devices is intensifying, and it’s no surprise given their rapid adoption. Over 1.3 million wearable devices were sold in just the first seven months of 2025 - a 35% jump compared to the same period the previous year [9]. With this surge comes an unprecedented amount of sensitive health data being generated outside traditional clinical environments. For organizations, compliance isn’t just about meeting legal standards - it’s about managing risks on a practical level.
The complexity of compliance is compounded by the overlapping regulations these devices face. A single wearable might need to comply with HIPAA in a clinical setting, the FTC's Health Breach Notification Rule in a consumer environment, and state-specific laws like Washington's MHMDA or Maryland's stringent ban on selling sensitive health data - even when users provide consent [3][5]. Successfully navigating these intersecting frameworks requires a robust and continuous risk management strategy that addresses security, compliance, and privacy at every level.
Tools like Censinet RiskOps™ are stepping in to simplify this process. By centralizing risk assessments, automating vendor evaluations, and supporting stringent cybersecurity measures like encryption and multi-factor authentication, platforms like these help healthcare organizations implement consistent safeguards across their data systems [1][3].
Ultimately, organizations that treat privacy compliance as an ongoing effort - not a one-time task - will be better equipped to handle the challenges ahead. This mindset aligns with the evolving regulatory landscape in the U.S. and abroad. As federal legislation like S.B. 3097 progresses and state laws grow stricter, the stakes for falling behind - both financially and reputationally - will only grow.
FAQs
Does HIPAA protect data from my fitness tracker or smartwatch?
Fitness trackers and smartwatches often fall outside the scope of HIPAA protections. Since these devices are generally not considered "covered entities" under HIPAA, the privacy of the data they collect isn't regulated by this law.
What should my company do first to comply with overlapping U.S. state and FTC rules?
To navigate the complex web of U.S. state and FTC regulations for wearable health devices, it’s crucial to stay informed about shifting privacy laws and adopt clear, transparent data practices. Start by making sure your privacy policies are straightforward and explain exactly how sensitive health data is collected, used, and shared. Also, offer users simple ways to opt out of data collection.
Regularly review your compliance with any new or upcoming regulations. Additionally, investing in strong cybersecurity measures can help manage risks and bolster the security of your data systems.
If I sell wearables globally, what’s the fastest way to handle GDPR consent and data transfers?
To meet GDPR requirements when selling wearables internationally, it's crucial to establish a clear system for gaining explicit user consent before processing sensitive health data, such as heart rate or sleep patterns. For transferring data across borders, consider GDPR-approved methods like Standard Contractual Clauses (SCCs) or Binding Corporate Rules (BCRs). Additionally, automating compliance workflows can simplify risk assessments and help you stay aligned with privacy regulations more efficiently.
